X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3504) 3504
Book Review (482) 482
Publication (134) 134
Newsletter (49) 49
Conference Proceeding (16) 16
Book Chapter (13) 13
Dissertation (5) 5
Magazine Article (2) 2
Newspaper Article (2) 2
Book / eBook (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2675) 2675
humans (1990) 1990
iloprost (1832) 1832
male (1304) 1304
female (1063) 1063
animals (954) 954
iloprost - pharmacology (756) 756
middle aged (676) 676
prostacyclin (674) 674
adult (643) 643
hypertension, pulmonary - drug therapy (622) 622
iloprost - therapeutic use (598) 598
pulmonary hypertension (567) 567
iloprost - administration & dosage (486) 486
vasodilator agents - therapeutic use (459) 459
inhaled iloprost (431) 431
rats (419) 419
cardiac & cardiovascular systems (413) 413
epoprostenol - pharmacology (404) 404
aged (403) 403
treatment outcome (389) 389
therapy (360) 360
abridged index medicus (355) 355
respiratory system (350) 350
hypertension, pulmonary - physiopathology (336) 336
vasodilator agents - administration & dosage (336) 336
pharmacology & pharmacy (328) 328
administration, inhalation (282) 282
double-blind (281) 281
bosentan (269) 269
epoprostenol - therapeutic use (267) 267
sildenafil (267) 267
epoprostenol - analogs & derivatives (261) 261
surgery (260) 260
hypertension (255) 255
peripheral vascular disease (255) 255
medicine, general & internal (252) 252
pulmonary arterial hypertension (242) 242
dose-response relationship, drug (227) 227
vasodilator agents - pharmacology (226) 226
survival (217) 217
time factors (212) 212
in vitro techniques (211) 211
arterial-hypertension (209) 209
prostacyclin analog (207) 207
antihypertensive agents - therapeutic use (205) 205
drug therapy, combination (202) 202
epoprostenol (200) 200
infusions, intravenous (200) 200
disease (198) 198
drug therapy (189) 189
biochemistry & molecular biology (187) 187
nitric-oxide (185) 185
epoprostenol - administration & dosage (180) 180
rheumatology (177) 177
care and treatment (172) 172
prostaglandins (168) 168
hypertension, pulmonary - etiology (167) 167
sildenafil citrate (163) 163
hemodynamics - drug effects (159) 159
platelet aggregation - drug effects (159) 159
research (159) 159
blood pressure - drug effects (156) 156
ischemia (155) 155
nitric oxide (155) 155
scleroderma (148) 148
treprostinil (146) 146
rabbits (141) 141
systemic sclerosis (141) 141
continuous intravenous epoprostenol (139) 139
mice (135) 135
cells, cultured (132) 132
hypertension, pulmonary - diagnosis (132) 132
medicine & public health (131) 131
oral sildenafil (130) 130
platelet aggregation inhibitors - therapeutic use (130) 130
blood platelets - drug effects (129) 129
cyclic amp - metabolism (129) 129
antihypertensive agents - administration & dosage (126) 126
inhaled nitric-oxide (125) 125
adolescent (124) 124
endothelin receptor antagonists (121) 121
infusion (121) 121
prospective studies (121) 121
iloprost - adverse effects (118) 118
vascular resistance - drug effects (117) 117
placebo-controlled trial (115) 115
platelet aggregation inhibitors - pharmacology (114) 114
transplantation (113) 113
aerosolized iloprost (112) 112
risk factors (110) 110
follow-up studies (109) 109
rats, wistar (109) 109
expression (108) 108
inhibition (108) 108
receptors, epoprostenol (108) 108
hemodynamics (107) 107
scleroderma, systemic - complications (107) 107
sulfonamides - therapeutic use (107) 107
disease models, animal (106) 106
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3112) 3112
German (199) 199
French (93) 93
Italian (48) 48
Spanish (39) 39
Russian (25) 25
Turkish (22) 22
Chinese (13) 13
Portuguese (11) 11
Japanese (8) 8
Polish (6) 6
Korean (4) 4
Hungarian (2) 2
Norwegian (2) 2
Persian (2) 2
Danish (1) 1
Dutch (1) 1
Lithuanian (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, pp. e52248 - e52248
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 09/2001, Volume 104, Issue 11, pp. 1218 - 1222
Journal Article
中华医学杂志:英文版, ISSN 0366-6999, 2017, Volume 130, Issue 4, pp. 382 - 391
Background: The clinical significance of acute vasoreactivity testing (AVT) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) remains... 
Chronic thromboembolic pulmonary hypertension | Calcium channel blocker treatment | Iloprost | Acute vasoreactivity testing | INHALED ILOPROST | Acute Vasoreactivity Testing | EMBOLISM | MEDICINE, GENERAL & INTERNAL | Chronic Thromboembolic Pulmonary Hypertension | Calcium Channel Blocker Treatment | ARTERIAL-HYPERTENSION | CALCIUM-CHANNEL BLOCKERS | ASSOCIATION | ENDARTERECTOMY | Iloprost - administration & dosage | Atrial Natriuretic Factor - metabolism | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Familial Primary Pulmonary Hypertension - drug therapy | Administration, Inhalation | Hypertension, Pulmonary - physiopathology | Male | Endarterectomy | Familial Primary Pulmonary Hypertension - physiopathology | Protein Precursors - metabolism | Arterial Pressure - drug effects | Calcium Channel Blockers - administration & dosage | Adult | Female | Iloprost - therapeutic use | Aged | Hemodynamics - drug effects | Hypertension, Pulmonary - drug therapy | Retrospective Studies | Software | Vasodilator Agents - administration & dosage | Clinical trials | Care and treatment | Research | Analysis | Pulmonary hypertension | Vasoconstriction | Heart | Medical imaging | Statistical analysis | Laboratories | Pulmonary arteries | Critical care | Cardiovascular disease | Patients | Medicine | Hospitals | Intubation | Circulatory system | Thromboembolism | Respiration | Veins & arteries | Index Medicus | Original | Acute Vasoreactivity Testing; Calcium Channel Blocker Treatment; Chronic Thromboembolic Pulmonary Hypertension; Iloprost
Journal Article
Canadian Journal of Anesthesia / Journal canadien d'anesthesie, ISSN 0832-610X, 08/2019, Volume 66, Issue 8, p. 907
Perioperative right ventricular (RV) failure due to pressure overload from pulmonary hypertension (PH) worsens postoperative outcomes after cardiac surgery.... 
Hospital patients | Iloprost | Cardiac patients | Patient outcomes
Journal Article
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 02/2019, Volume 48, Issue 4, pp. 686 - 693
Systemic sclerosis (SSc) is an autoimmune chronic disease characterized by vascular impairment, immune dysfunction and collagen deposition. Raynaud’s... 
Digital ulcer | Iloprost | Raynaud’s phenomenon | Systemic sclerosis
Journal Article
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2013, Volume 144, Issue 1, pp. 55 - 62
Objective We hypothesized that nebulized iloprost would improve ventilation-perfusion matching in patients with pulmonary hypertension and ARDS as reflected by... 
Pulmonary/Respiratory | MULTICENTER CLINICAL-TRIAL | THERAPY | RESPIRATORY SYSTEM | DOUBLE-BLIND | AEROSOLIZED PROSTACYCLIN | ACUTE LUNG INJURY | VASCULAR-RESISTANCE | INHALED NITRIC-OXIDE | PROSTAGLANDIN E | TLC C-53 | RESPIRATORY-DISTRESS-SYNDROME | CRITICAL CARE MEDICINE | Respiratory Distress Syndrome, Adult - physiopathology | Iloprost - pharmacology | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Male | Hemodynamics - physiology | Dose-Response Relationship, Drug | Respiratory Mechanics - drug effects | Pulmonary Gas Exchange - drug effects | Adult | Female | Hypertension, Pulmonary - drug therapy | Respiratory Mechanics - physiology | Iloprost - administration & dosage | Vasodilator Agents - pharmacology | Comorbidity | Administration, Inhalation | Treatment Outcome | Hypertension, Pulmonary - epidemiology | Respiratory Distress Syndrome, Adult - drug therapy | Pulmonary Gas Exchange - physiology | Iloprost - therapeutic use | Aged | Hemodynamics - drug effects | Respiratory Distress Syndrome, Adult - epidemiology | Vasodilator Agents - administration & dosage | Acute respiratory distress syndrome | Iloprost | Care and treatment | Patient outcomes | Dosage and administration | Research | Hemodynamics | Pulmonary hypertension | Pulmonary gas exchange | Index Medicus | Abridged Index Medicus
Journal Article
Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, 01/2008, Volume 52, Issue 1, pp. 65 - 72
Background: Pulmonary hypertension (PHT) is common in patients undergoing mitral valve surgery and is an independent risk factor for the development of acute... 
right ventricular ejection fraction | pulmonary hypertension | mitral valve surgery | cardiopulmonary bypass | Right ventricular failure | pulmonary vascular resistance | inhaled iloprost | Cardiopulmonary bypass | Mitral valve surgery | Inhaled iloprost | Right ventricular ejection fraction | Pulmonary vascular resistance | Pulmonary hypertension | MANAGEMENT | PROSTACYCLIN | GRADIENT | PATHOPHYSIOLOGY | TRANSPLANTATION | RIGHT-VENTRICULAR DYSFUNCTION | AEROSOLIZED ILOPROST | CARDIAC-SURGERY | NITRIC-OXIDE | ANESTHESIOLOGY | ENDOTHELIN | right ventricular failure | Postoperative Complications - etiology | Echocardiography, Transesophageal | Prospective Studies | Iloprost - pharmacology | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Catheterization, Swan-Ganz | Male | Cardiac Output, Low - etiology | Milrinone - therapeutic use | Nitroglycerin - administration & dosage | Mitral Valve Insufficiency - complications | Vascular Resistance - drug effects | Female | Hypertension, Pulmonary - drug therapy | Cardiac Output, Low - drug therapy | Postoperative Complications - drug therapy | Monitoring, Intraoperative | Iloprost - administration & dosage | Vasodilator Agents - pharmacology | Mitral Valve Insufficiency - surgery | Nitroglycerin - therapeutic use | Administration, Inhalation | Stroke Volume - drug effects | Cardiopulmonary Bypass | Ventricular Dysfunction, Right - prevention & control | Ventricular Dysfunction, Right - etiology | Iloprost - therapeutic use | Aged | Infusions, Intravenous | Hypertension, Pulmonary - etiology | Mitral Valve Insufficiency - physiopathology | Vasodilator Agents - administration & dosage | Ventricular Dysfunction, Right - diagnostic imaging | Hypertension | Heart valve diseases | Vasodilators | Index Medicus
Journal Article
Archivos de Medicina del Deporte, ISSN 0212-8799, 11/2017, Volume 34, Issue 6, pp. 345 - 352
Journal Article